AsianScientist (Oct. 14, 2013) – Apollo Hospitals Enterprise and Medtronic have announced a collaboration to bring an affordable and portable hemodialysis system to India, which can help improve access to care for end stage renal disease (ESRD) patients who need renal replacement therapy (RRT).
This collaboration will leverage a Medtronic-developed technology platform, supported by clinical insight from Apollo. Both organizations envision a healthcare delivery system that addresses the critical need for dialysis solutions in India.
Specifically, the collaboration seeks improved accessibility, outcomes, affordability, operational ease, and environmental protection while providing hemodialysis services to ESRD patients requiring RRT.
Medtronic intends to develop and manufacture key components of this system in India, with an investment of more than US$25 million. For the first time, Medtronic is establishing an India R&D team that will focus on design, development and manufacturing of key components of the hemodialysis system in India. The commercial launch of the product is slated for 2016.
“Our partnership with Medtronic will help in fulfilling our vision of delivering better clinical outcomes through bench-to-bedside innovation,” said Dr. Prathap C Reddy, chairman of Apollo Hospitals.
“Our goal is to build a unique, internally developed system that will be portable, will lower costs, and will be more efficient in its use of water and other critical features than existing dialysis systems,” said Omar Ishrak, chairman and CEO of Medtronic.
Apollo Hospitals and Medtronic expect that a new portable system would broaden healthcare providers’ capability to serve patients from hospital to home, saving costs to the healthcare system overall.
——
Source: Medtronic.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
